Patients with arthritis undergoing surgery: how should we manage tumour necrosis factor blocking agents perioperatively?-A systematic literature review. [electronic resource]
Producer: 20140114Description: 253-7 p. digitalISSN:- 1976-2437
- Adalimumab
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis -- surgery
- Certolizumab Pegol
- Etanercept
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Immunoglobulin G -- therapeutic use
- Infections
- Infliximab
- Perioperative Period
- Polyethylene Glycols -- therapeutic use
- Postoperative Complications -- prevention & control
- Postoperative Period
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Retrospective Studies
- Risk
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.